
In 2021, approximately 8.3 million adults with Alzheimer's disease will be living in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). A substantial proportion of these elderly adults will live in the US and Japan, where the prevalence of Alzheimer's disease is highest.